Is telehealth allowed to prescribe Lamictal in Pennsylvania?

Introduction

The landscape of telepsychiatry has evolved dramatically since 2020, opening new doors for patients with bipolar disorder to access critical medications through virtual care. If you’re considering telehealth treatment for bipolar disorder, you likely have questions about what medications can legally be prescribed online, whether you’ll need in-person visits, and how the process works across different states.

This comprehensive guide examines the current legal framework for prescribing bipolar medications via telehealth in 2026, focusing on common mood stabilizers like Lithium, Lamictal (lamotrigine), and Seroquel (quetiapine). We’ll clarify federal and state regulations, provider requirements, and what you can expect as a patient seeking virtual bipolar treatment.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

The Legal Status of Telehealth Prescribing for Bipolar Disorder

Non-Controlled Status: The Key Distinction

The most important fact to understand about bipolar medications is their legal classification. Unlike medications for conditions like ADHD (which often involves stimulants) or anxiety (which might involve benzodiazepines), the primary medications for bipolar disorder are not controlled substances:

• Lithium – Not controlled (unscheduled)
• Lamotrigine (Lamictal) – Not controlled (unscheduled)
• Quetiapine (Seroquel) – Not controlled (unscheduled)

This distinction is crucial because non-controlled medications are subject to fewer restrictions for telehealth prescribing under federal law. The Ryan Haight Act’s requirements for in-person examinations before prescribing apply only to controlled substances—not to these bipolar medications.

Federal Regulations: Clear Path for Telehealth

From a federal standpoint, there is no prohibition on prescribing these mood stabilizers via telehealth. As long as the provider conducts a proper clinical evaluation through a video visit that meets the standard of care, they can legally prescribe non-controlled bipolar medications in all 50 states.

The DEA and HHS have been focused primarily on regulating telehealth prescribing of controlled substances (currently operating under a temporary extension of COVID-era flexibilities through December 2026), but those rules don’t apply to the main bipolar medications.

State-by-State Overview: Generally Permissive

While state laws add another layer to telehealth regulations, most states have embraced telehealth prescribing for non-controlled medications:

• All states permit telehealth prescribing of non-controlled medications
• None of our reviewed states require in-person visits specifically for mood stabilizers
• Some states (e.g., New Hampshire) require periodic evaluations (which can be done via telehealth) for ongoing treatment

The bottom line: For bipolar disorder patients seeking lithium, lamotrigine, or quetiapine, telehealth is a legally viable option across the United States.

What to Expect: The Telehealth Prescribing Process

Initial Evaluation and Diagnosis

A legitimate telehealth provider will conduct a thorough evaluation before prescribing any bipolar medication:

1. Comprehensive psychiatric assessment via video (45-60 minutes typically)
2. Detailed medical history including previous treatments, family history, and any medication side effects
3. Mental status examination to assess your current symptoms
4. Differential diagnosis to rule out other conditions that might mimic bipolar disorder
5. Discussion of treatment options including risks and benefits

At Klarity Health, psychiatric providers conduct these evaluations with the same thoroughness as in-person visits, using secure video platforms that comply with privacy regulations. This comprehensive approach ensures both legal compliance and appropriate medical care.

Prescription Fulfillment

If medication is deemed appropriate, your telehealth provider will:

• Send an electronic prescription directly to your preferred pharmacy
• Typically start with a 30-day supply for new patients (potentially with refills once stabilized)
• Provide instructions for follow-up appointments
• Order any necessary lab tests (especially important for lithium)

Most states now mandate electronic prescribing, which adds a layer of security and prevents prescription fraud. Your telehealth prescription is just as valid as one from an in-person visit.

Follow-Up Requirements

For ongoing bipolar treatment via telehealth:

• Regular video follow-ups (typically every 1-3 months)
• Lab monitoring as clinically indicated (especially for lithium)
• Medication adjustments based on response and side effects
• Documentation of your progress and treatment plan

In New Hampshire, state law requires an evaluation at least annually for continued treatment, but this can be done via telehealth. Most providers will recommend more frequent check-ins, particularly when starting or adjusting medications.

Who Can Prescribe: Provider Credentials and Authority

Prescriber Types and Requirements

Various types of healthcare providers can legally prescribe bipolar medications via telehealth, but their authority varies by state:

• Psychiatrists (MD/DO) can prescribe in all 50 states via telehealth
• Nurse Practitioners (NPs) can prescribe these medications in all states, but:
• In ~30 states, NPs have full independent practice authority
• In ~20 states, NPs require collaborative agreements with physicians
• Physician Assistants (PAs) can prescribe with physician supervision in all states

For example, in New York, a psychiatric nurse practitioner with independent practice authority can evaluate you via telehealth and prescribe lithium without physician oversight. In Texas, an NP can do the same but must have a prescriptive authority agreement with a physician.

Klarity Health connects patients with appropriately licensed and credentialed providers based on their state of residence, ensuring all prescriptions meet legal requirements.

Interstate Licensing Considerations

It’s important to note that telehealth providers must be licensed in the state where the patient is physically located during the appointment. Multi-state licensed providers can treat patients across several states, but the provider must still follow the specific telehealth laws of each patient’s state.

Special Clinical Considerations for Telehealth Bipolar Treatment

Monitoring Requirements

While legally permissible, telehealth bipolar treatment does involve clinical considerations that providers must address:

• For Lithium: Providers must arrange for blood level monitoring, kidney function tests, and thyroid function tests
• For Lamotrigine: Monitoring for rash and other side effects requires clear patient education
• For Quetiapine: Metabolic monitoring (weight, blood glucose, lipids) should be arranged

Telehealth providers can order these tests at labs near you and review results remotely. At Klarity Health, providers develop monitoring plans that balance convenience with appropriate medical oversight.

Patient Eligibility and Safety Planning

Not all bipolar patients are ideal candidates for telehealth treatment. Most telehealth providers will assess:

• Severity of symptoms (severe mania or psychosis may require in-person evaluation)
• Suicidality risk (active suicidal ideation typically requires higher levels of care)
• Ability to participate in video visits and follow treatment plans
• Access to emergency services if needed

Providers will also establish an emergency plan, including local resources you can access if your condition worsens between appointments.

State-Specific Highlights and Recent Changes

Recent telehealth policy developments affect bipolar treatment in several states:

California

California explicitly allows the ‘appropriate prior examination’ to be conducted via telehealth. The state is also transitioning to full practice authority for nurse practitioners by 2026, which will expand access to telehealth psychiatric care.

New York

In 2025, New York adopted rules requiring in-person visits for controlled substances (with exceptions), but these rules do not affect non-controlled bipolar medications like lithium and lamotrigine, which remain fully accessible via telehealth.

Texas

Texas mental health teleprescribing is explicitly permitted for non-controlled medications. While Texas restricts telehealth prescribing of certain controlled substances, those restrictions don’t apply to the primary bipolar medications.

Florida

Florida allows telehealth prescribing of non-controlled medications without any in-person requirement. NPs in Florida practice under protocols with physicians and can prescribe non-controlled medications via telehealth.

New Hampshire

New Hampshire now requires that patients receiving ongoing prescription medications via telehealth have an evaluation at least annually, but this evaluation can be conducted via telehealth rather than in-person.

Common Misconceptions About Telehealth Prescribing

Several myths persist about telehealth psychiatric care:

Myth 1: ‘Online psychiatrists can’t prescribe real medications’

Reality: Licensed telehealth providers can prescribe the same FDA-approved medications as in-person providers. For bipolar disorder, there’s no legal difference between a prescription written after a video

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=announced%20a%20fourth%20temporary%20extension,while%20permanent%20rules%20are%20finalized
• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,this%20flexibility%20has%20been%20prolonged
• https://www.sheppardhealthlaw.com/2017/07/articles/health-information-technology/online-pharmacies/#:~:text=,Internet%20without%20a%20valid%20prescription
• https://www.jdsupra.com/legalnews/telehealth-and-in-person-visits-6106096/#:~:text=In%20late%202024%2C%20the%20U,V
• https://www.jdsupra.com/legalnews/telehealth-and-in-person-visits-6106096/#:~:text=person%20evaluation%20requirement%20under%20the,provide%20short%20term%20stability%20while
• https://www.ama-assn.org/health-care-advocacy/advocacy-update/jan-24-2025-national-advocacy-update#:~:text=telemedicine%20registrations%20for%20prescribing%20Schedule,Like%20the%20buprenorphine%20rule
• https://www.dea.gov/press-releases/2025/12/31/dea-extends-telemedicine-flexibilities-ensure-continued-access-care#:~:text=The%20Fourth%20Temporary%20Extension%2C%20along,flexibilities%20under%20the%20fourth%20temporary
• https://www.jdsupra.com/legalnews/telehealth-and-in-person-visits-6106096/#:~:text=1,long%20as%20the%20issuing%20provider
• https://www.jdsupra.com/legalnews/telehealth-and-in-person-visits-6106096/#:~:text=1,a
• https://www.jdsupra.com/legalnews/telehealth-and-in-person-visits-6106096/#:~:text=5,a%20physician%20must%20generally%20use